b. riley - Search News

B. Riley, Foghorn Therapeutics

B. Riley Securities Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation

Fintel reports that on January 30, 2025, B. Riley Securities initiated coverage of Foghorn Therapeutics (NasdaqGM:FHTX) with a Buy recommendation. Analyst Price Forecast Suggests 207.54% Upside As of January 28,

Business Insider · 8h

Foghorn Therapeutics initiated with a Buy at B. Riley

B. Riley initiated coverage of Foghorn Therapeutics (FHTX) with a Buy rating and $10 price target. The firm says its investment thesis centers

Hosted on MSN · 1h

Foghorn Therapeutics a new buy at B Riley on tumor fighting technology

B. Riley has initiated Foghorn Therapeutics (NASDAQ:FHTX) at buy citing the company's development of SMARCA2 inhibitors to fight tumors. The investment bank has a $10 price target (~151% upside based on Jan.

Hosted on MSN9d

Bottom 100 Stocks to Buy: Is B. Riley Financial Uninvestable?

The markets were closed on Monday for Martin Luther King Jr. Day, which also marked the inauguration of Donald J. Trump, the ...

13h

What is B. Riley’s Forecast for CUBI Q1 Earnings?

B. Riley issued their Q1 2025 earnings estimates for Customers Bancorp in a research note issued to investors on Monday, ...

3don MSN

B. Riley upgrades Redwire on growth potential from Edge Autonomy acquisition

Learn about the latest financial trends and strategies in our comprehensive article written by a financial expert.

ClearPoint Neuro price target raised to $20 from $15 at B. Riley

B. Riley analyst Kyle Bauser raised the firm’s price target on ClearPoint Neuro (CLPT) to $20 from $15 and keeps a Buy rating ...

B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...

13h

FY2024 EPS Estimates for Ladder Capital Cut by B. Riley

Analysts at B. Riley reduced their FY2024 earnings estimates for shares of Ladder Capital in a research report issued to clients and investors on Monday, January 27th. B. Riley analyst R. Binner now ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results